UAE Estrogen Replacement Therapy Market Size & Outlook

The estrogen replacement therapy market in the UAE is expected to reach a projected revenue of US$ 100.8 million by 2033. A compound annual growth rate of 5.2% is expected of the UAE estrogen replacement therapy market from 2026 to 2033.
Revenue, 2025 (US$M)
$67.5
Forecast, 2033 (US$M)
$100.8
CAGR, 2026 - 2033
5.2%
Report Coverage
UAE

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

UAE estrogen replacement therapy market, 2021-2033 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

UAE estrogen replacement therapy market highlights

  • The UAE estrogen replacement therapy market generated a revenue of USD 67.5 million in 2025 and is expected to reach USD 100.8 million by 2033.
  • The UAE market is expected to grow at a CAGR of 5.2% from 2026 to 2033.
  • In terms of segment, combined estrogen + progestin therapy (ept) was the largest revenue generating therapy type in 2025.
  • Bioidentical hormone therapy is the most lucrative therapy type segment registering the fastest growth during the forecast period.


Estrogen replacement therapy market data book summary

Market revenue in 2025USD 67.5 million
Market revenue in 2033USD 100.8 million
Growth rate5.2% (CAGR from 2026 to 2033)
Largest segmentCombined estrogen + progestin therapy (ept)
Fastest growing segmentBioidentical hormone therapy
Historical data2021 - 2024
Base year2025
Forecast period2026 - 2033
Quantitative unitsRevenue in USD million
Market segmentationEstrogen-only therapy (ET), Combined estrogen + progestin therapy (EPT), Bioidentical hormone therapy
Key market players worldwidePfizer Inc, AbbVie Inc, Bayer AG, Eli Lilly and Co, Novo Nordisk A/S ADR, Novartis AG ADR, Merck KGaA, F. Hoffmann-La Roche AG, Viatris Inc, Teva Pharmaceutical Industries Ltd


Other key industry trends

  • In terms of revenue, UAE accounted for 0.6% of the global estrogen replacement therapy market in 2025.
  • Country-wise, Canada is expected to lead the global market in terms of revenue in 2033.
  • In Middle East & Africa, Saudi Arabia estrogen replacement therapy market is projected to lead the regional market in terms of revenue in 2033.
  • Saudi Arabia is the fastest growing regional market in Middle East & Africa and is projected to reach USD 345.5 million by 2033.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Estrogen Replacement Therapy Market Companies

Name Profile # Employees HQ Website
F. Hoffmann-La Roche AG View profile - - -
Viatris Inc View profile 38000 1000 Mylan Boulevard, Canonsburg, PA, United States, 15317 https://www.viatris.com
Novo Nordisk A/S ADR View profile 66015 Novo Alle 1, Bagsvaerd, Denmark, 2880 https://www.novonordisk.com
Eli Lilly and Co View profile 43000 Lilly Corporate Center, Indianapolis, IN, United States, 46285 https://www.lilly.com
Bayer AG View profile 99723 Kaiser-Wilhelm-Allee 1, Leverkusen, NW, Germany, 51368 https://www.bayer.com
Pfizer Inc View profile 88000 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 https://www.pfizer.com
AbbVie Inc View profile 50000 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 http://www.abbvieinvestor.com
Merck KGaA View profile 62345 Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 https://www.emdgroup.com
Teva Pharmaceutical Industries Ltd View profile 37851 124 Dvora HaNevi’a Street, Tel Aviv, Israel, 6944020 https://www.tevapharm.com
Novartis AG ADR View profile 76057 Lichtstrasse 35, Basel, Switzerland, 4056 https://www.novartis.com

UAE estrogen replacement therapy market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to estrogen replacement therapy market will help companies and investors design strategic landscapes.


Combined estrogen + progestin therapy (ept) was the largest segment with a revenue share of 49.33% in 2025. Horizon Databook has segmented the UAE estrogen replacement therapy market based on estrogen-only therapy (et), combined estrogen + progestin therapy (ept), bioidentical hormone therapy covering the revenue growth of each sub-segment from 2021 to 2033.


Reasons to subscribe to UAE estrogen replacement therapy market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of UAE estrogen replacement therapy market databook

  • Our clientele includes a mix of estrogen replacement therapy market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the UAE estrogen replacement therapy market , including forecasts for subscribers. This country databook contains high-level insights into UAE estrogen replacement therapy market from 2021 to 2033, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

UAE Therapy Type - Estrogen Replacement Therapy Market size, 2025 - 2033 (US$M)

UAE Estrogen Replacement Therapy Market Outlook Share, 2025 & 2033 (US$M)

UAE Therapy Type - Estrogen Replacement Therapy Market size, 2025 - 2033 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online